SOPHiA GENETICS Advances Blood Cancer Genomic Testing With New Myeloid Solutions
SOPHiA GENETICS Advances Blood Cancer Genomic Testing With New Myeloid Solutions Targets DNA variants and RNA fusion genes for blood cancers, including challenging variants CALR, CEBPA, ASXL1, FLT3 News provided by Share this article BOSTON and LAUSANNE, Switzerland, June 1, 2021 /PRNewswire/ -- SOPHiA GENETICS, the creator of a global data-sharing network that advances data-driven medicine, today released SOPHiA DDM™ for Blood Cancers, novel blood cancer testing solutions across the entire workflow from setup, genomic testing, and in-house advanced analytics. The solutions target the m...
Source: prnewswire.com